IZOKIBEP (IL-17A)
Oct 07 2022
To assess the safety, tolerability, and immunogenicity of izokibep in subjects with active non-infectious, intermediate-, posterior- or pan-uveitis requiring high-dose steroids.
Read MoreGALE
Oct 07 2022
To assess the long-term efficacy and safety of multiple intravitreal injections of APL-2 in subjects with geographic atrophy secondary to age-related macular degeneration.
Read MoreCONCERTO
Oct 07 2022
To determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telescope (IMT) in patients with moderate-severe central vision loss due to late-stage age-related macular degeneration (AMD).
Read MoreVILLA
Oct 07 2022
To evaluate safety and tolerability of the Port Delivery System (PDS) in patients with neovascular age-related macular degeneration (nAMD).
Read MoreHONU
Oct 07 2022
The purpose of this study is to assess iAMD disease progression, by the timeline and rates of conversion for high-risk iAMD at baseline to more advanced AMD stages.
Read MoreTED
Aug 02 2022
A Phase 2b, Randomized, Double-Mask, Placebo-Controlled, Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Linsitinib in Subjects with Active, Moderate to Severe Thyroid Eye Disease (TED)
Read More
DOVS Announces Transition for Phase 2 Medical Student Education Director
Jul 05 2022
A 15-year veteran of the University of Wisconsin Department of Ophthalmology and Visual Sciences will soon be stepping aside from his role as Director of Medical Student Education. But he’ll be handing the reigns to…
Read More